MRP 560/-STRIP

Composition

Each film coated Tablet Contains:Mirabegron IP 50mg. + (As Extended Release) Solifenacin Succinate IP 5mg. + Excipients q.s.

Doses

As Directed by Physician

Description

Mirabegron+Solifenacin is used in the treatment of Overactive bladder (OAB) symptoms. Mirabegron + Solifenacin is a combination of two medicines: Mirabegron and Solifenacin. Mirabegron is a beta 3-receptor agonist. It works by activating the receptor in the bladder, causing the bladder muscles to relax.